sumatriptan has been researched along with Anaplastic Oligodendroglioma in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siderov, J | 1 |
| Zalcberg, J | 1 |
| Chambers, B | 1 |
| Fabinyi, G | 1 |
1 other study available for sumatriptan and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
Migraine following the use of a 5-hydroxytryptamine antagonist.
Topics: Ergotamine; Female; Humans; Middle Aged; Migraine Disorders; Oligodendroglioma; Ondansetron; Sumatri | 1993 |